ICON PLC (ICLR) is a Healthcare · Diagnostics & Research company listed on NASDAQ. Price $163.02 (-3.92%), Market cap $9.05B, P/E ratio 15.66, 52-week low–high $80.08 ~ $202.92.
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strat
Financial statements, price targets, institutional (13F) holdings and related news for ICON PLC are updated in real time on BlackAll Trade.
ICON PLC trades at $163.02 (-3.92%). Real-time quotes and charts are available on BlackAll Trade.
ICON PLC has a market cap of about $9.05B. Its P/E ratio is 15.66.
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The co